Metsera to Present at Upcoming September Investor Conferences

Core Insights - Metsera, Inc. is a clinical-stage biopharmaceutical company focused on developing next-generation medicines for obesity and metabolic diseases [2] - The company is advancing a diverse portfolio of therapies, including oral and injectable incretin, non-incretin, and combination therapies, aimed at addressing multiple therapeutic targets in the evolving weight loss treatment landscape [2] Company Overview - Metsera was founded in 2022 and is headquartered in New York City [2] - The company emphasizes its commitment to accelerating innovative treatments for obesity and metabolic diseases [2] Upcoming Events - CEO Whit Bernard will present at the Cantor Global Healthcare Conference on September 3, 2025, from 3:20 to 3:50 P.M. EDT [5] - Bernard will also present at the Wells Fargo 2025 Healthcare Conference on September 4, 2025, from 4:30 to 5:05 P.M. EDT [5] Investor Relations - Metsera utilizes its website as a distribution channel for material information, with financial and important updates accessible through the Investors & News section [3] - Investors can sign up for email alerts to receive updates about the company [3]